Evidence map›Paper›PMID 31156004›Full record

ArticlePharmaceutical biology2019

Silk peptide treatment potentiates natural killer cell activity

Sun-Hee Jang, Mi-Sun Oh, Hyang-Im Baek, Ki-Chan Ha, Jeong-Yong Lee, Yong-Suk Jang

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sun-Hee Janga Department of Molecular Biology and the Institute for Molecular Biology and Genetics , Chonbuk National University , Jeonju , Korea.
Mi-Sun Ohb Worldway Co., Ltd , Sejong , Korea.
Hyang-Im Baekc Healthcare Claims and Management Inc , Jeonju , Korea.
Ki-Chan Hac Healthcare Claims and Management Inc , Jeonju , Korea.
Jeong-Yong Leeb Worldway Co., Ltd , Sejong , Korea.
Yong-Suk Janga Department of Molecular Biology and the Institute for Molecular Biology and Genetics , Chonbuk National University , Jeonju , Korea.
Jeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BombyxAnimalsCell SurvivalCytokinesDose-Response Relationship, DrugHumansImmunologic FactorsK562 CellsKiller Cells, NaturalPeptide FragmentsSilkSpleenCytokinesImmunologic FactorsPeptide FragmentsSilkcomplementary therapyCytolytic activitytarget cell lysis

Identifiers

PMID31156004
PMCPMC6567191
OpenAlexW2947800917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.